TY - JOUR
T1 - Ecallantide
T2 - An alternative treatment of refractory angioedema in adolescents with systemic lupus erythematosus
AU - Kanchongkittiphon, Watcharoot
AU - Kabil, Nora
AU - Bacharier, Leonard B.
AU - Kitcharoensakkul, Maleewan
N1 - Funding Information:
Conflicts of interest: L. B. Bacharier has worked as a consultant for DBV, Merck, Boehringer Ingelheim, Vectura, Sanofi, Teva, Novartis/Genentech, GlaxoSmithKline, Circassia, and Regeneron; received honoraria for being on the Speakers Bureau for Teva, Boehringer Ingelheim, Novartis, AstraZeneca, and Sanofi/Regeneron; received research support from Sanofi and Vectura; has research interests: National Institutes of Health/National Heart, Lung, and Blood Institute, the National Institute of Allergy and Infectious Diseases; and has organizational interests in the following: the American Academy of Allergy, Asthma & Immunology Annual Meeting Planning Committee, Journal of Allergy and Clinical Immunology Associate Editor, and Director of American Board of Allergy and Immunology, GINA Science Committee. The rest of the authors declare that they have no relevant conflicts of interest.
PY - 2020/3
Y1 - 2020/3
UR - http://www.scopus.com/inward/record.url?scp=85072634168&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2019.08.052
DO - 10.1016/j.jaip.2019.08.052
M3 - Article
C2 - 31541765
AN - SCOPUS:85072634168
VL - 8
SP - 1115
EP - 1116
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
SN - 2213-2198
IS - 3
ER -